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Summary Background: Since 2005, at least 38 facial transplantations have been performed
worldwide. We herein describe the surgical technique and 1-year clinical outcome in Finland’s
first face transplant case.
Methods: A 34-year-old male who had a severe facial deformity following ballistic trauma in
1999 underwent facial transplantation at the Helsinki University Hospital on 8th February 2016.
Three-dimensional (3D) technology was used to manufacture donor and recipient patient-
specific osteotomy guides and a donor face mask. The facial transplant consisted of a Le Fort II
maxilla, central mandible, lower ⅔ of the midface muscles, facial and neck skin, oral mucosa,
anterior tongue and floor of mouth muscles, facial nerve (three bilateral branches), and bilat-
eral hypoglossal and buccal nerves.
Results: At 1-year follow-up, there have thus far been no clinical or histological signs of
rejection. The patient has a good aesthetic outcome with symmetrical restoration of the mobile
central part of the face, with recovery of pain and light touch sensation to almost the entire
facial skin and intraoral mucosa. Electromyography at 1 year has confirmed symmetrical muscle
activity in the floor of the mouth and facial musculature, and the patient is able to produce
spontaneous smile. Successful social and psychological outcome has also been observed. Post-
operative complications requiring intervention included early (nasopalatinal fistula, subman-
dibular sialocele, temporomandibular joint pain and transient type 2 diabetes) and late (intraoral
wound and fungal infection, renal impairment and hypertension) complications.
* Corresponding author. Department of Plastic Surgery, Töölö Hospital, Helsinki University Hospital, Topeliuksenkatu 5, P.O. Box 00029
HUS, Helsinki, Finland.
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Conclusion: At 1 year, we report an overall good functional outcome in Finland’s first face
transplant.
© 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by
Elsevier Ltd. All rights reserved.
Introduction
The past 10 years have seen rapid development in the field
of facial vascularised composite allotransplantation (VCA)
with promising functional, aesthetic and psychological
outcomes.1 Facial VCA is the only reconstructive option avail-
able that can successfully replace lost or severely damaged
central facial units such as the oral commissure, maxilla,
nose and eyelids as functional outcomes with conventional
reconstructive techniques invariably fall short. To date, it is
estimated that at least 38 facial transplantations (including
Finland’s first case) have been performed worldwide.
However, only two-thirds of all face transplants have been
published in the peer-reviewed literature with details on
surgical technique and clinical outcomes.2–21 Furthermore,
transparent description of all complications and revision
surgery has been somewhat lacking in this still new but largely
experimental field of reconstructive surgery.2 Thus far, even
though the experience of centres worldwide performing facial
transplantation has proved its surgical feasibility with good
functional outcomes, only now are we beginning to see the
long-term outcomes.1,7,22
We herein describe our experience in facial allotransplan-
tation with details on the surgical procedure and clinical
outcome at 12 months. In addition, a thorough review is
provided of all complications encountered and revision sur-
gical procedures performed to date.
Methods: recipient and donor
Recipient
Evaluation pre-transplantation
A 34-year-old male who had sustained a self-inflicted
facial gunshot injury in 1999 was selected for facial
transplantation (Figure 1). He had suffered loss of themidface
soft tissues and nose, maxilla and central mandible and had
complete bilateral blindness. He had previously undergone
28 surgical procedures including five microvascular recon-
structions. However, the patient suffered from persistent,
recurrent soft tissue and hardware infections. He had limited
lip closure and tongue projection due to an absent tip and
floor of the mouth scarring. There were consequent prob-
lems with eating and speech further exacerbated by limited
mouth opening and unsatisfactory dentition as dental
implants were not possible. In addition, the patient suffered
from absent nasal breathing. Clinically, there was normal
bilateral masseter function, and facial nerve innervation of
orbicularis oculi was symmetrical and normal. Facial nerve
innervation to orbicularis oris was symmetrical, but muscle
function was severely inhibited by scarring. There was absent
function of the zygomaticus muscles, but normal function of
depressor anguli oris muscles. 3D CT scans of the facial skel-
eton revealed marked loss of facial height and central facial
collapse (Figure 2). The patient was otherwise healthy, blood
group O, rhesus positive, and immunologically had a panel
reactive antibody status of 33%. Serological status included
cytomegalovirus and Epstein-Barr virus positivity. The patient
underwent a 2-year psychological evaluation that involved
three semi-structured interviews by a clinical psychologist.
These included initial assessment of any psychiatric diagno-
ses or substance abuse, followed by evaluation of the
patient’s readiness for the operation, prediction of psycho-
logical reactions, possible risk factors and compliance with
treatment after transplantation. The patient’s ability to
receive and process information was also assessed to evalu-
ate his capability to give informed consent and ultimately
was deemed to be suitable for facial VCA. Whilst the patient
was strongly motivated for the treatment, he was also fully
informed about all the risks, postoperative course and pos-
sible sequelae.
Figure 1 Illustration of patient preoperatively, donor facial allograft and post transplantation.
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3D planning of osteotomy and cutting guides
We used Planmeca® (Planmeca Oy, Helsinki, Finland), a
Helsinki-based company who specialise in 3D imaging and
CAD/CAM (computer-aided design and computer-aidedmanu-
facturing) software, to manufacture customised recipient
osteotomy guides and generic guides for the donor. The
generic donor osteotomy guides were produced according to
the measurements derived from the patient’s planned
resection.
Donor
Consent for facial tissue donation was obtained only after
consent for solid organ donation was obtained. The donor
was selected on the basis of matching of gender, skin colour,
suitable age, facial dimensions and dentition. The donor was
blood group compatible, and the T- and B- cell cross match
was negative. Because of the anonymity requirements for
organ donors in Finland, no other detailed information can
be disclosed about the donor.
On the day of transplantation, 3D CT angiogram scans
were obtained from the donor and transferred to Planmeca®
for virtual 3D planning of customised donor patient oste-
otomy guides. Virtual planning was complete within 3 h, and
osteotomy lines were fine-tuned so that the donor’s maxilla
and mandible would fit as well as possible. The customised
osteotomy guides were printed during the time of facial
procurement surgery, and the actual guides were produced
and ready for use prior to the performing of the osteotomies.
Digital photographs were also taken of the donor face for 3D
modelling and printing of a donor facemask using a new
process earlier described by our institution.23
Facial allograft procurement
A brain-dead, beating heart donation was planned to enable
thorough haemostasis during procurement and limit bleed-
ing after revascularisation. The donor was a multi-organ
donor of the heart, lungs, liver, kidneys and pancreas. Fol-
lowing inspection of the internal abdominal organs, upper
facial dissection commenced simultaneously with the abdom-
inal organ transplant surgeons. All skin and soft tissues from
the glabellar and infraorbital regions with incisions running
along the subciliary margins of the lower eyelids and includ-
ing the orbicularis oculi muscles were dissected. Maxillary
osteotomy guides were fixed in place to the nasal radix,
medial orbital margins and both zygomatic maxillary pro-
cesses. The infraorbital nerves were identified in the infe-
rior orbital fissure and labelled. Bilateral preauricular
dissection of the facial nerve branches to the cheek and lips
was performed at the anterior edge of the parotid glands.
Dissection then continued anteriorly along the masseteric
fascia, and within the buccal fat pad, the buccal nerves
were identified and included in the facial allograft. The
external carotid arteries and internal jugular veins were
then dissected bilaterally, with preservation of the facial
Figure 2 3D CT scan of skeletal anatomy revealing marked loss of facial height and central facial collapse, and 3D CT scan at 12
months postoperatively.
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vessels and submandibular glands within the allograft. The
hyoid bone and anterior floor of the mouth muscles were
also included in the allograft along with intraoral cheek
mucosa up to the anterior tonsillar pillars, ventral portion of
the tongue and hypoglossal nerves. Bilateral ascending ramus
mandibular sagittal split osteotomies were then performed
with identification and inclusion of the inferior alveolar
nerves. Le Fort II osteotomies (including the nose, nasal
cartilage, septum and nasal bones) were performed using
the customised cutting guides. The maxillary segment was
then levered caudally with division of the nasal septum, and
there was inclusion of about 1 cm of soft palate along with
the hard palate. The facial allograft was then isolated on the
vascular pedicles. Simultaneously, a right radial forearm flap
was also harvested to act as a sentinel flap.
All organs were then perfused simultaneously with the
facial tissues perfused through a cannula placed in the aortic
arch with cold Wisconsin solution. Following removal of the
heart and lungs, the facial allograft and sentinel flap were
detached, further perfused on a back table and then subse-
quently transported in ice water slurry. Following procure-
ment of the other abdominal organs, a cephalic vein graft
and fascia lata grafts were also harvested, and finally, a 3D
manufactured face mask was attached to the donor facial
defect.
Recipient debridement
Simultaneous recipient patient debridement was com-
menced after tracheostomy. Definitive debridement com-
menced once the donor facial allograft was confirmed to be
viable and perfused through the vascular pedicles. Le Fort II
maxillary and central mandible segments were removed using
customised osteotomy guides. Central facial skin and soft
tissue including all poor quality tissue was removed along
with the anterior floor of the mouth, ventral scarred tongue
and a variable portion of poor quality soft palate tissue
consisting of earlier free flap tissue. Recipient vessels were
dissected in a very scarred neck (internal jugular vein
branches bilaterally, external carotid artery on the left and
facial artery on the right) along with bilateral hypoglossal
nerves. Facial nerve branches were dissected to lie in prox-
imity to the subsequent donor target muscles. Remnants of
the orbicularis oris muscle with scar tissue attached to it was
split in the midline and left in situ with its own neurovascular
supply intact. In addition, remnants of the zygomaticmuscles
were spared for subsequent attachment. Infraorbital and
inferior alveolar sensory nerves could not be identified
because of extensive scarring.
Facial tissue transplantation
Before the restoration phase started, mandible sagittal oste-
otomies using 3D-printed custom-made donor osteotomy
guides were performed on the side table. The donor facial
maxilla and central mandible were first fixed into place.
Arterial anastomoses were performed between external
carotid arteries on the left and facial arteries on the right
(with a vein graft). Venous anastomoses involved the donor
allograft facial vein to a branch of the internal jugular vein
on the right and two further venous anastomoses on the left.
Three branches (zygomatic and buccal) of the facial nerve
on both sides were anastomosed as distally as possible, and
bilateral end-to-side hypoglossal nerve anastomoses were
also carried out. The recipient’s own divided medial ends of
the orbicularis oris muscle were tunnelled subcutaneously
within the donor allograft’s upper and lower lip tissue and
sutured about 2 cm medial to the contralateral commissures
under appropriate tension. The remnants of the patient’s
partly functioning zygomatic muscles were attached to the
equivalent muscular region in the allograft. Bilateral buccal
sensory nerves were sutured end-to-end along with bilater-
ally both lip and cheek facial nerve branches. Excess skin in
the neck and preauricular regions was preserved to allow for
postoperative biopsies for monitoring of rejection and for
postoperative swelling and avoidance of tension at the suture
line. Simultaneously, transplantation of the sentinel (radial
forearm) flap was performed to the right lateral thigh using
the lateral femoral circumflex vessels as recipient vessels.
Immunosuppression and infection control
Induction immunosuppression involved rabbit antithymocyte
globulin (1.5 mg/kg) for 4 days, and tacrolimus-based triple
therapy (target 13–16 ng/ml) with mycophenolate mofetil
and methylprednisolone (500 mg iv) with tapering doses.
Maintenance immunosuppression entailed mycophenolate
mofetil (1 g × 2), tacrolimus (with a goal of initial trough
levels of 6–8 ng/ml) and prednisolone. Regular punch biop-
sies were obtained from the sentinel flap and facial allograft
skin.
The antibiotic protocol included clindamycin and
ciprofloxacin for 3weeks, caspofungin for 5weeks, ganciclovir




The duration of facial allograft harvest was 6 h (total
multiorgan harvesting duration was 10 h). The duration of
the recipient patient’s debridement was 10 h and facial res-
toration 9 h. Total cold ischaemia time was 3 h 15 min. The
total surgical time was thus 19 h, and the entire procedure
fromnotification of a potential donor to completion of surgery
took a total of 32 h. The recipient operative blood loss was
3350 ml, and 7 units of packed red blood cells were trans-
fused along with 4 units (4 × 400 ml) of albumin. There were
no intraoperative complications.
Post-surgery
The supplemental file describes the postoperative event
timeline. The length of stay in the Intensive Care Unit was 9
days, and the patient was decannulated on day 20. He
resumed a full oral diet on day 25 and was discharged home
after 57 days. Careful follow-up arrangements were made
with close corporation with the social services. Regular fre-
quent outpatient follow-up with various members of the
surgical team was arranged at first twice weekly and then at
twice-monthly intervals after 6 months.
Clinical outcome at 12 months follow-up
To date (15 months), there have been no signs of acute
rejection with prednisolone tapered to a current dose of
The Helsinki Face Transplantation: Surgical aspects and 1-year outcome 135
6 mg/day. Tacrolimus trough levels are currently main-
tained at 6–8 ng/ml. All facial allograft and sentinel flap
biopsy results have so far been negative for rejection.
The patient reports an overall positive impact of the face
transplant on his psychosocial well-being. Figure 1 shows the
inset of the donor facial allograft. He had a successful aes-
thetic outcome with symmetrical restoration of the mobile
central part of face. Pain and light touch sensation has been
restored almost to the entire face and oral cavity, but dis-
criminatory sensation of less than 16 mm is still lacking
(Figure 3). Motor activity is present in all of the muscle
groups, and this has been confirmed objectively by
electomyographical (EMG) (Table 1. EMG results at 10
months). The patient also produces spontaneous smile. Mouth
opening has now improved to greater than 31 mm, and the
patient is eating a normal diet. The patient has maintained
the original good dental occlusion at 12 months, and there
has not been any change in the position of the maxilla. There
have been no signs of psychological disturbance postopera-
tively. For the assessment of the effect of facial VCA on the
patient’s quality of life (QOL), we applied the generic 15D
health related QOL instrument24 and the European
Organisation for Research and Treatment of Cancer QOL
Questionnaire (EORTC QLQ-Head & Neck 35 module). At 12
months follow-up, for 11 of the 15D instrument domains and
for 33 of the 35 EORTC questions, the patient rated normal
or near-normal function. In comparison to the preoperative
status, improvement in speaking and breathing in the former
and improvement in four domains (dry mouth, olfaction,
hoarseness and appearance) of the latter questionnaire was
observed.
Postoperative complications (Figure 4)
Surgical complications
On postoperative day (POD) 7, the patient had developed a
nasopalatinal fistula because of partial separation of the
allograft hard palate and patient’s remaining soft palate,
which required three surgical attempts until closure at POD
425. A salivary gland sialocele required ultrasound drainage
of sterile saliva at POD 20. This occurred despite prophylac-
tic intraoperative Botulinum toxin injections to donor sub-
mandibular glands to reduce salivary production. The patient
suffered from temporary left temporomandibular joint (TMJ)
Figure 3 Sensation at 3, 6 and 12 months. Grey shading (light touch); red hash (sharp touch); 2-point discrimination when <22 mm.
Table 1 EMG assessment of facial muscles at 10 months
follow-up.
Muscle Right Left
Lower orbicularis oculi ++ ++
Nasalis ++ +
Orbicularis oris ++ +++
Zygomaticus major ++ +++
Genioglossus (XII) + ++
XII Hypoglossal nerve; + severe impairment; ++ moderate impair-
ment; +++ functional.
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pain and restricted mouth opening as a result of imperfect
mandible position. At 6 weeks, a 3D CT scan revealed good
dental occlusion, but the transplanted segment of mandible
was slightly too wide with the right mandible turned out-
wards (Figure 2). An intraoral wound developed in the right
upper gingiva at 5 months, and this led to a local Candida
infection of the maxilla requiring debridement and three
dental extractions.
Immunosuppression related-complications
There was a transient steroid-induced type 2 diabetes for 3
months. Mild to moderate renal impairment has been moni-
tored since day 16. Hypertension has been treated from
postoperative week 5.
Discussion
There have been at least 38 facial transplants performed to
date involving varying amounts of facial soft tissue with or
without a portion of the facial skeleton. Aesthetic and func-
tional outcomes have thus far been encouraging.1–21,25 We
herein report our first case of facial transplantation in which
the lower two-third of the face was transplanted en bloc
with a Le Fort II maxilla and central mandible. At 12 months,
our patient has a good aesthetic result with a symmetrical
mobile part of the central face and motor activity in all
muscle groups. The patient reports that the face transplant
has had a positive impact on his psychological well-being and
achieves an overall good score on the 15D QOL assessment.
The financial cost of the transplant operation was 75,000
euros, and the overall cost for the first year following trans-
plantation was 190,000 euros.
Patient selection for facial VCA requires careful multidis-
ciplinary assessment, and it is noteworthy that our patient
had complete bilateral blindness as a consequence of his
original facial trauma. Although blindness has been consid-
ered by some to be a contraindication to facial VCA, a posi-
tion paper by Carty et al concluded that the inclusion of
blind patients in facial VCA programs should be advocated
for on the basis of functional, social, rehabilitative and ethical
grounds.26 Certainly for our patient, the emphasis was the
restoration of function as a key indication for facial VCA, and
we have not observed any negative outcomes related to the
patient’s blindness.
In severe self-inflicted ballistic trauma, conventional
reconstructive procedures often fail to restore the essential
facial functions (eating, breathing and speech). Earlier reports
have confirmed the feasibility and promising functional and
psychosocial outcomes after facial VCA after ballistic
trauma.13,15,17,27,28 However, Kiwanuka et al report in 2 patients
with self-inflicted ballistic trauma only incomplete sensory
restoration and restricted masticatory movements at 1 year
follow-up. Additionally, in only 1 patient, clear functional
and psychosocial improvements were observed. The authors
concluded that this could be partly attributed to the increased
incidence in rejections and infections in the patient with a
worse outcome.28 Our patient, also a victim of a self-
inflicted ballistic trauma, clearly demonstrated an improve-
ment in psychosocial and physical functional outcomes at 1
year. Although our patient also had early restriction of man-
dibular movements due to TMJ pain that required diet mod-
ification, over time, his mandibular movements improved,
and the patient could resume a normal diet by 3–4 months
post transplant. With regard to patients with a history of
psychiatric illness and self-harm, the importance of thor-
ough psychiatric screening prior to selection for facial VCA
must be stressed, and it must be ensured that an adequate
social support network is in place following surgery.
With regard to sensory reintegration, because of severe
scarring of the recipient patient, only the buccal sensory
nerves were available for anastomosis. However, improving
pain and light touch sensation to the entire facial allograft
has developed already at 12 months. We have observed that
sensation developed initially from the periphery of the
allograft for both pain and light touch. Siemionow M et al
have also corroborated this finding, and demonstrated that
recovery of close to normal sensation can be expected fol-
lowing facial transplantation with or without repair of the
sensory nerves.29 Hence, an interesting question could be
posed, whether or not sensory nerves should be dissected at
all to save valuable time.
The importance of preserving the patient’s own function-
al units is an important issue that we considered carefully
in our case. Despite a normally innervated orbicularis oris
muscle, his lip function was very poor owing to severe scar-
ring. Therefore, we preserved his orbicularis muscle and
tunnelled this into the facial allograft’s upper and lower lip
tissue and attached the patient’s partly functioning zygo-
matic muscles to the equivalent muscular region in the
allograft. In the early postoperative period, he was noted
to have good resting tone to the lip and zygomatic muscula-
ture. At 10 months EMG assessment, reasonable to good
function was observed in the transplanted muscle groups.
Furthermore, facelift procedures have not been necessary,
and only the excision of excess skin has been performed.
The Boston group recently reviewed their own and other
centres’ functional outcomes, and they observed that im-
provement in facial expression has been reported in 76% of
all facial VCAs.25 Prior to transplantation, the patient had
severe restriction in his tongue movement due to extensive
scarring in the floor of the mouth. He had anterior tongue
and floor of the mouth muscles transplanted with side-to-
end anastomosis of the hypoglossus nerve. Tongue movements
were already seen by 3 months postoperatively, and at 12
months, the patient could move his tongue 3 cm. We con-
clude that the transplantation of the anterior tongue is
effective and can have remarkable functional benefit for
the patient.
Figure 4 Postoperative complications.
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The most serious complication we have encountered has
been the presence of a palatal fistula that has caused prob-
lems with speech in particular. The cause of the palatal
fistula was probably two-fold: reduced vascularity of the
posterior part of the transplanted maxilla and because of
the severe loss of facial height, the recipient and donor soft
palates were at different levels leading to tension at the
palatal repair.
With regard to immunology, we have so far not seen any
acute rejection episodes with close, regular follow-up. His-
topathological analyses of biopsies taken from the facial
allograft and sentinel flap have been negative for rejection,
and we have been able to reduce the steroid dose to 6 mg/
day and maintain a tacrolimus trough level of 6–8 ng/ml. A
previous study by Kueckelhaus et al has demonstrated the
usefulness of the sentinel flap in rejection monitoring by
providing a reliable correlation between biopsies taken from
the facial allograft and sentinel flaps.30 In our patient, immu-
nosuppression has resulted in chronic renal impairment,
hypertension and a transient type 2 diabetes. In the recent
review by Lantieri et al, at long-term follow-up of 7 patients,
3 had hypertension, with 1 requiring therapy, and all patients
had a reduction in the glomerular filtration rate.7 A recent
report by Kanitakis et al22 has described the possibility of
chronic rejection in human VCAs, but its pathogenesis, diag-
nosis and treatment remain unresolved.
Aycart et al recently reviewed all published QOL out-
comes after facial VCA performed worldwide.31 They noted
that QOL outcomes have been reported in only 14 facial VCA
recipient cases and that the instruments used have varied
widely. Overall, however, they concluded that there seems
to be an improvement in the QOL following facial VCA. We
applied the validated 15D health related QOL instrument24
that assesses 15 different dimensions. Its use in head and
neck cancer patients has been previously reported by our
institution.32 We observed a clear improvement in several of
the 15D and EORTC QOL domains when comparing pre- and
postoperative scores.
Conclusions
Finally, we can report that our experience is in alignment
with that of other facial VCA centres, in that facial trans-
plantation is technically feasible with the possibility of good
functional outcomes with the caveat that revision surgery is
likely to be necessary. A recent update by Sosin M and Rodri-
guez ED2 concluded that there is an essential need for the
timely reporting of all cases of facial VCA with complete
complication and outcome profiles. With this in mind, we
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